Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Agios Pharmaceuticals

Explore full profile

Biopharmaceutical company discovering and developing therapeutics for cancer metabolism

Cambridge, United StatesFounded 2008Biotech & Life Sciences
Valuation $1.21B Market cap · Aug/2026
Revenue $148M Latest reported FY

At a glance

Founded
2008
Headquarters
Cambridge, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A1 investor entered at this stage

Series B and later5 investors entered at this stage

  • Bristol-Myers Squibb
  • University of Toronto
  • University of Pennsylvania
  • Harvard University
  • Celgene

Talent

Book a demo to see the people
Employees mapped 642 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 15 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 6 startups shown

Former Agios Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.

Xaira TherapeuticsEst. 2023
Marc Tessier-LavigneUnited States
Signal score92
ELucidata.ioEst. 2015
AJAbhishek JhaUnited States
Signal score75
Auron TherapeuticsEst. 2018
Kate YenUnited States
Signal score69
Clear Creek BioEst. 2017
David ScaddenUnited States
Signal score68
Mythic TherapeuticsEst. 2017
Brian FiskeUnited States
Signal score61
1 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇺🇸 United States96.6%
🇮🇳 India2%
🇨🇭 Switzerland0.3%
🇳🇱 Netherlands0.2%
🇮🇹 Italy0.2%
Top 5 of 8 shown
Web traffic by country
24K monthly visits
across markets
🇺🇸 United States75.4%
🇬🇧 United Kingdom5.4%
🇨🇦 Canada5%
🇮🇳 India5%
🇫🇷 France3.8%
Top 5 markets shown

Patents

Estimated portfolio value
$318M

96 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Agios Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Agios Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles